Lucia Sanchez-Gandullo
Salamanca, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs.
Journal: Cancer letters
Published: September 12, 2022
HER3 in cancer: from the bench to the bedside.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 05, 2022
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
Journal: International journal of molecular sciences
Published: April 14, 2022
Novel ADCs and Strategies to Overcome Resistance to Anti-HER2 ADCs.
Journal: Cancers
Published: December 10, 2021
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 03, 2021
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2021
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies.
Journal: EMBO molecular medicine
Published: September 24, 2019
Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms.
Journal: Cancer letters
Published: September 19, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026